SAFETY AND TOLERABILITY OF HUMAN IMMUNE GLOBULIN SUBCUTANEOUS, 20% (SCIG 20%) IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES (PIDD) IN EUROPE AND NORTH AMERICA

Mapping Intimacies ◽

10.26226/morressier.57bc1758d462b80290b4cfef ◽

2016 ◽

Author(s):

L. Yel

Keyword(s):

North America ◽

Immune Globulin ◽

Primary Immunodeficiency ◽

Primary Immunodeficiency Diseases ◽

Immunodeficiency Diseases ◽

Download Full-text

Efficacy, Safety, and Pharmacokinetics of a Novel Human Immune Globulin Subcutaneous, 20 % in Patients with Primary Immunodeficiency Diseases in North America

Journal of Clinical Immunology ◽

10.1007/s10875-016-0327-9 ◽

2016 ◽

Vol 36 (7) ◽

pp. 700-712 ◽

Author(s):

Daniel Suez ◽

Mark Stein ◽

Sudhir Gupta ◽

Iftikhar Hussain ◽

Isaac Melamed ◽

...

Keyword(s):

North America ◽

Immune Globulin ◽

Primary Immunodeficiency ◽

Primary Immunodeficiency Diseases ◽

Immunodeficiency Diseases ◽

Download Full-text

Onboarding Experience of Pediatric Patients With Primary Immunodeficiency Diseases With Subcutaneous Human Immune Globulin 20% (Ig20Gly)

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2017.12.851 ◽

2018 ◽

Vol 141 (2) ◽

pp. AB268

Author(s):

Kenneth Paris ◽

Iftikhar Hussain ◽

Sudhir Gupta ◽

Ping Wang ◽

Barbara McCoy ◽

...

Keyword(s):

Immune Globulin ◽

Primary Immunodeficiency ◽

Pediatric Patients ◽

Primary Immunodeficiency Diseases ◽

Immunodeficiency Diseases ◽

Download Full-text

Infusion Parameters and Adverse Events in Patients With Primary Immunodeficiency Diseases Who Switched to Subcutaneous Human Immune Globulin 20% (Ig20Gly) From Intravenous or Subcutaneous Immune Globulin

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2017.12.850 ◽

2018 ◽

Vol 141 (2) ◽

pp. AB267

Author(s):

Iftikhar Hussain ◽

Kenneth Paris ◽

Amy Darter ◽

Lisa J. Kobrynski ◽

Todd Berner ◽

...

Keyword(s):

Adverse Events ◽

Immune Globulin ◽

Primary Immunodeficiency ◽

Primary Immunodeficiency Diseases ◽

Immunodeficiency Diseases ◽

Download Full-text

O015 Tolerability of a new human immune globulin subcutaneous, 20% preparation in primary immunodeficiency diseases

Annals of Allergy Asthma & Immunology ◽

10.1016/j.anai.2016.09.375 ◽

2016 ◽

Vol 117 (5) ◽

pp. S5-S6

Author(s):

S. Gupta ◽

M. Stein ◽

I. Melamed ◽

I. Hussain ◽

K. Paris ◽

...

Keyword(s):

Immune Globulin ◽

Primary Immunodeficiency ◽

Primary Immunodeficiency Diseases ◽

Immunodeficiency Diseases ◽

Download Full-text

P251 Safety/tolerability of human immune globulin subcutaneous, 20% in pediatric patients with primary immunodeficiency diseases

Annals of Allergy Asthma & Immunology ◽

10.1016/j.anai.2016.09.264 ◽

2016 ◽

Vol 117 (5) ◽

pp. S97

Author(s):

K. Paris ◽

B. Dérfalvi ◽

I. Hussain ◽

E. Haddad ◽

F. Dicso ◽

...

Keyword(s):

Immune Globulin ◽

Primary Immunodeficiency ◽

Pediatric Patients ◽

Primary Immunodeficiency Diseases ◽

Immunodeficiency Diseases ◽

Download Full-text

Analysis of Safety and Tolerability Data in Pediatric Patients with Primary Immunodeficiency Diseases from Two Phase 2/3 Studies of Human Immune Globulin Subcutaneous, 20%

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2016.12.703 ◽

2017 ◽

Vol 139 (2) ◽

pp. AB217

Author(s):

Kenneth Paris ◽

Elie Haddad ◽

Iftikhar Hussain ◽

Nicholas Brodszki ◽

Amy Liebl Darter ◽

...

Keyword(s):

Immune Globulin ◽

Primary Immunodeficiency ◽

Pediatric Patients ◽

Phase 2 ◽

Primary Immunodeficiency Diseases ◽

Two Phase ◽

Immunodeficiency Diseases ◽

Tolerability Data ◽

Download Full-text

Onboarding Experience of Patients With Primary Immunodeficiency Diseases Who Switched to Subcutaneous Human Immune Globulin 20% (Ig20Gly) From Intravenous or Subcutaneous Immune Globulin 10%

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2017.12.081 ◽

2018 ◽

Vol 141 (2) ◽

pp. AB26

Author(s):

Sudhir Gupta ◽

Iftikhar Hussain ◽

Kenneth Paris ◽

Mark Stein ◽

Barbara McCoy ◽

...

Keyword(s):

Immune Globulin ◽

Primary Immunodeficiency ◽

Primary Immunodeficiency Diseases ◽

Immunodeficiency Diseases ◽

Download Full-text

Long term use of intravenous immune globulin in patients with primary immunodeficiency diseases: Inadequacy of current dosage practices and approaches to the problem

Journal of Clinical Immunology ◽

10.1007/bf00918362 ◽

1982 ◽

Vol 2 (S2) ◽

pp. 15S-21S ◽

Author(s):

Rebecca H. Buckley

Keyword(s):

Immune Globulin ◽

Primary Immunodeficiency ◽

Intravenous Immune Globulin ◽

Primary Immunodeficiency Diseases ◽

Immunodeficiency Diseases

Download Full-text

Pharmacokinetic Analysis (PK) of Immune Globulin Subcutaneous (Human), 10% (IGSC) Administered Intravenously or Subcutaneously in Subjects with Primary Immunodeficiency Diseases (PIDD)

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2010.12.077 ◽

2011 ◽

Vol 127 (2) ◽

pp. AB17-AB17 ◽

Author(s):

H. Leibl ◽

R.L. Wasserman ◽

I. Melamed ◽

M. Stein ◽

W. Engl ◽

...

Keyword(s):

Immune Globulin ◽

Primary Immunodeficiency ◽

Pharmacokinetic Analysis ◽

Primary Immunodeficiency Diseases ◽

Immunodeficiency Diseases

Download Full-text

Safety, Efficacy, and Pharmacokinetics of Flebogamma®5% [Immune Globulin Intravenous (Human)] for Replacement Therapy in Primary Immunodeficiency Diseases

Journal of Clinical Immunology ◽

10.1023/b:joci.0000029108.18995.61 ◽

2004 ◽

Vol 24 (4) ◽

pp. 389-396 ◽

Author(s):

Melvin Berger ◽

Paul J. Pinciaro

Keyword(s):

Replacement Therapy ◽

Immune Globulin ◽

Primary Immunodeficiency ◽

Primary Immunodeficiency Diseases ◽

Immunodeficiency Diseases

Download Full-text